ReviewTherapeutic advances in respiratory disease

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience.

Arjun Khunger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.